Rafael Holdings

0 followers

‌

Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.

Industries

Biotechnology

Headquarters

Newark, United States

Employees

11-50

Links

Org chart

William Conkling

CEO

William Conkling

Collapse

David Polinsky

Chief Financial Officer

Ari Landon

Director Of Innovation

Board & advisors

Chairman

Director

Director

Director

Director

Director

Teams

Management

7 members

Offices

Similar companies

Tango Therapeutics

2 followers

Vaxcyte

2 followers

Ensoma

1 follower

Aurion Biotech

1 follower

Phylos

1 follower

Cellares

2 followers

Tyra Biosciences

1 follower

Kriya Therapeutics

1 follower

On Target Laboratories

1 follower

Thermo Fisher Scientific

180 followers

Genentech

163 followers

Explore companies